Covered recipient · General Payments record
LITA FAYE WARISE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,679.44
- Reported across 189 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $372.64 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $203.50 | 21 |
| GlaxoSmithKline, LLC. | $51.03 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $42.45 | 3 |
| Acerta Pharma LLC | $22.79 | 1 |
| Sandoz Inc. | $21.70 | 1 |
| Aurinia Pharma U.S., Inc. | $16.90 | 1 |
| Genentech USA, Inc. | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.35 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379741 | CMS |
| ABBVIE INC. | $15.45 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379743 | CMS |
| ABBVIE INC. | $7.14 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379745 | CMS |
| ABBVIE INC. | $5.54 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379747 | CMS |
| ABBVIE INC. | $2.32 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379749 | CMS |
| ABBVIE INC. | $4.39 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379751 | CMS |
| ABBVIE INC. | $9.78 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379753 | CMS |
| ABBVIE INC. | $12.89 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379755 | CMS |
| ABBVIE INC. | $3.59 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379757 | CMS |
| ABBVIE INC. | $8.52 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379759 | CMS |
| ABBVIE INC. | $7.45 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379761 | CMS |
| ABBVIE INC. | $5.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379763 | CMS |
| ABBVIE INC. | $27.92 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379765 | CMS |
| ABBVIE INC. | $8.04 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379767 | CMS |
| ABBVIE INC. | $8.93 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379769 | CMS |
| ABBVIE INC. | $17.72 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379771 | CMS |
| ABBVIE INC. | $8.82 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379773 | CMS |
| ABBVIE INC. | $8.64 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379775 | CMS |
| ABBVIE INC. | $15.73 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379777 | CMS |
| ABBVIE INC. | $5.62 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379779 | CMS |
| ABBVIE INC. | $0.46 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108379781 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.79 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105797968 | CMS |
| Aurinia Pharma U.S., Inc. | $16.90 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150702128 | CMS |
| Genentech USA, Inc. | $14.27 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133171185 | CMS |
| GlaxoSmithKline, LLC. | $21.41 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116341012 | CMS |
| GlaxoSmithKline, LLC. | $15.14 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116688325 | CMS |
| GlaxoSmithKline, LLC. | $14.48 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116085884 | CMS |
| Novartis Pharmaceuticals Corporation | $14.26 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087348756 | CMS |
| Novartis Pharmaceuticals Corporation | $13.41 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087348758 | CMS |
| Novartis Pharmaceuticals Corporation | $14.78 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087348762 | CMS |
| Sandoz Inc. | $21.70 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089364293 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.